Heartlight System
Device Atrial Fibrillation
General payments
$4,581,760
Research payments
$531,233
Through program year 2025, $4,581,760 in general payments and $531,233 in research payments were reported against Heartlight System (Atrial Fibrillation).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $156,641 | 20 |
| 2024 | General | $1,248,182 | 202 |
| 2024 | Research | $244,106 | 24 |
| 2023 | General | $1,512,608 | 312 |
| 2023 | Research | $35,875 | 13 |
| 2022 | General | $150,000 | 1 |
| 2021 | General | $1,670,970 | 16 |
| 2021 | Research | $94,611 | 24 |
Breakdown
The top 5 of 53 recipients; each share is of general payments naming this product in 2024.
Each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.
The top 5 of 15 states; each share is of general payments naming this product in 2024 where a state was reported.
Records
531 general · 81 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.